Results 231 to 240 of about 7,749,363 (311)
What's cooking? The effect of temperature on the immune response. [PDF]
Old JM, Dixon B.
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
An abnormal immune response masquerading as infectious conditions. [PDF]
Kieu Q, Leyden B.
europepmc +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Integrating behaviour, physiology, and immune response to social stress in fish. [PDF]
Winberg S, Hubená P.
europepmc +1 more source
Uncovering G Protein‐Coupled Receptors: Novel Targets and Biomarkers for Predicting Glioma Prognosis
ABSTRACT Background Low‐grade gliomas (LGG) exhibit significant heterogeneity and recurrence risk. G protein‐coupled receptors (GPCR) contribute to glioma malignant progression, but their prognostic value remains unclear. This work attempts to formulate a GPCR‐based outcome‐predicting model for LGG. Methods Based on TCGA LGG data, the enrichment scores
Jun Yang +4 more
wiley +1 more source
Association Between Immunosuppressive Cell Populations and Immune Response to Influenza Vaccination in Younger and Older Adults. [PDF]
Di Placido D +13 more
europepmc +1 more source
The Podophage PM16 Enhances the Humoral Immune Response Against <i>Proteus mirabilis</i>. [PDF]
Al Allaf L +5 more
europepmc +1 more source

